You may be eligible to participate in the CONTROL-RA study if you:
- Are between the ages of 18 and 75
- Have been diagnosed with moderate to severe rheumatoid arthritis
- Receiving treatment with an FDA-approved TNFi (including biosimilars) that is injected into the skin for at least 12 weeks
- Are willing to consider changes to your rheumatoid arthritis treatment